
Yaron Conforti, CEO of Novamind
by Nick Opich on May 13, 2021 in podcast
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS
by Nick Opich on May 13, 2021 in podcast
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Android | RSS
No new episode of the Green Rush this week, instead we’re replaying an old favorite, our conversation with Yaron Conforti, CEO and Director of Novamind Ventures, which delivers psychedelic therapies to patients suffering from treatment resistant psychological conditions at its Cedar Psychiatry clinics in Utah.
Novamind is evolving the model of regulated psychedelic medicine by treating patients with ketamine-assisted psychotherapy at its four Cedar Psychiatry clinics in Utah; creating complementary evidence-based therapy modalities that enhance patient outcomes; and, building a network of outpatient mental health clinics and clinical research sites in jurisdictions with established regulations for the use of psychedelics.
Our hosts Anne and Nick spoke with Yaron to chat with him about the more than 4,000 ketamine-assisted psychotherapy treatments Novamind has administered, the Company’s expansion plans beyond its home base of Utah and Novamind’s RTO onto the CSE.
And no worries, we will be back with a brand new episode next week – so don’t lean back, lean and enjoy!
Yaron Conforti, Chief Executive Officer of Novamind
Yaron Conforti is the Chief Executive Officer and Director of Novamind. He’s an entrepreneur and the principal of Emmcap Corp., an investor in venture-stage companies. Previously, he served in senior investment banking roles at Desjardins Securities and Sandfire Securities, and in CEO, CFO and corporate director roles for private and public companies.
Links and mentions in the show
Links to the guest’s company and social media accounts
Show Credits:
This episode was hosted by Anne Donohoe and Nick Opich of KCSA Strategic Communications.
Special thanks to our Program Director Shea Gunther.
You can learn more about how KCSA Cannabis can help your cannabiz by visiting www.kcsa-cannabis.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels:
Twitter: @The_GreenRush
Instagram: @thegreenrush_podcast
LinkedIn: https://www.linkedin.com/company/thegreenrushpodcast/
Facebook: https://www.facebook.com/TheGreenRushPodcast/
YouTube: https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true
Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. This week Lewis Goldberg and Anne Donohoe are back for a new episode with special guest Ken Jordan, CEO, Co-Founder and Editorial Director of Lucid News. Ken joins us this week […]
Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. This week Anne Donohoe and Emmaline Lewis are back for a new episode with special guest Dr. Dennis McKenna, Ethnopharmacologist and the Director and President of the McKenna Academy of Natural […]
Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. This week Anne Donohoe and Nick Opich are back for a new episode with special guest Jess Tyler, Chief Revenue and Experience Officer at MJBiz and MJBizCon. Jess joins us this […]
Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture. This week Nick Opich and Lewis Goldberg are back for a new episode with special guest Brigadier General (Ret.) Stephen N. Xenakis, MD, Executive Director of the American Psychedelic Practitioners Association […]